Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer
暂无分享,去创建一个
R. Pai | J. Berek | T. Longacre | A. Mills | J. Ford | Sofia Liou
[1] A. Ariza,et al. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome. , 2014, Human pathology.
[2] A. Karnezis,et al. Association of Tumor Morphology With Mismatch-repair Protein Status in Older Endometrial Cancer Patients: Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome , 2014, The American journal of surgical pathology.
[3] Alexander M. Metcalf,et al. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Stewart. Genetic Testing Strategies in Newly Diagnosed Endometrial Cancer Patients Aimed at Reducing Morbidity or Mortality from Lynch Syndrome in the Index Case or Her Relatives , 2013, PLoS currents.
[5] C. Eng,et al. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. , 2013, Gynecologic oncology.
[6] A. Spurdle,et al. Improving identification of lynch syndrome patients: A comparison of research data with clinical records , 2013, International journal of cancer.
[7] R. Kuiper,et al. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients , 2013, Familial Cancer.
[8] J. Church,et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Potter,et al. Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.
[10] B. Clarke,et al. Identifying Lynch Syndrome in Patients With Endometrial Carcinoma: Shortcomings of Morphologic and Clinical Schemas , 2012, Advances in anatomic pathology.
[11] J. Weitzel,et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] B. Clarke,et al. Use of Mismatch Repair Immunohistochemistry and Microsatellite Instability Testing: Exploring Canadian Practices , 2012, The American journal of surgical pathology.
[13] Aung Ko Win,et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Sargent,et al. Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications , 2012, Clinical Cancer Research.
[15] B. Clarke,et al. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation‐positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries , 2012, Cancer.
[16] J. Ledermann,et al. Family History and Women With Ovarian Cancer: Is it Asked and Does it Matter? , 2011, International Journal of Gynecologic Cancer.
[17] Laetitia Huiart,et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.
[18] R. Pai,et al. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas , 2011, Modern Pathology.
[19] Michael S. Rentz,et al. Immunohistochemical Staining for DNA Mismatch Repair Proteins in Intestinal Tract Carcinoma: How Reliable are Biopsy Samples? , 2011, The American journal of surgical pathology.
[20] P. Møller,et al. Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers , 2010, Journal of Medical Genetics.
[21] H. Hampel. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[22] B. Karlan,et al. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. , 2010, Gynecologic oncology.
[23] P. Radice,et al. Lynch Syndrome—Related Endometrial Carcinomas Show a High Frequency of Nonendometrioid Types and of High FIGO Grade Endometrioid Types , 2010, International journal of surgical pathology.
[24] Laura H. Tang,et al. Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome: A 2-antibody Panel May be as Predictive as a 4-antibody Panel , 2009, The American journal of surgical pathology.
[25] A. de la Chapelle,et al. Identifying Lynch syndrome , 2009, International journal of cancer.
[26] W. Frankel,et al. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. , 2009, Gynecologic oncology.
[27] K. Kosarin,et al. Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities , 2009, The American journal of surgical pathology.
[28] D. Bodurka,et al. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Kwon,et al. Cost‐effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome , 2008, Cancer.
[30] J. Shia. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. , 2008, The Journal of molecular diagnostics : JMD.
[31] P. Propping,et al. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome , 2008, The Journal of pathology.
[32] R. Broaddus,et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] B. Karlan,et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. , 2007, Gynecologic oncology.
[34] W. Frankel,et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.
[35] P. Peltomäki,et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] W. Frankel,et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.
[37] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[38] H. Hollema,et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A. Zwinderman,et al. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree , 2001, Journal of medical genetics.
[40] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[41] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[42] Alexander M. Metcalf,et al. Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review , 2013, Familial Cancer.
[43] Julie O. Culver,et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. , 2011, The Lancet. Oncology.
[44] J. Dungan. Lynch Syndrome Screening Strategies Among Newly Diagnosed Endometrial Cancer Patients , 2010 .
[45] R. Coleman. Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome , 2007 .
[46] R. Broaddus,et al. Gynecologic Cancers in Lynch Syndrome/HNPCC , 2005, Familial Cancer.